Polynovo Ltd (ASX:PNV)
share price: (EoD)
earnings per share:
dividends per share:
Polynovo Ltd (ASX:PNV) is an Australian medical device company that designs, develops, and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology.
Polynovo Ltd (ASX:PNV) share price
Polynovo Ltd (ASX:PNV) passive income
Polynovo Ltd (ASX:PNV) share price news
PoloNovo (ASX:PNV) shares continue to slide – is this a buying opportunity?
In just a few weeks, nearly $1 billion has been wiped from the market capitalisation of medical device manufacturer PolyNovo Ltd (ASX:PNV). Are shares cheap today?
S&P/ASX 200 morning report – ALU, ARB & PNV shares in focus
The S&P/ASX 200 (INDEXASX:XJO) is expected to open slightly lower on Wednesday. Altium (ASX:ALU) and PolyNovo (ASX:PNV) shares are in the news.
Polynovo (ASX:PNV) shares drop on HY21 trading update
The Polynovo Ltd (ASX:PNV) share price is down 6% in early trading after giving a HY21 update.
2 ASX MedTech stocks to watch like a hawk in 2021
Two key sectors that I’ll be researching for growth opportunities in 2021 are healthcare and technology. Here are two I’ll be watching closely next year.
Are PolyNovo (ASX:PNV) shares a buy despite surging 80% in 3 months?
Shares in wound care treatment provider PolyNovo Ltd (ASX: PNV) have gone on a rampage these last few months. Are PolyNovo shares a buy at today’s levels?
3 ASX growth shares to add to your watchlist
With around 2,185 stocks on the ASX, I’ve narrowed it down to three ASX growth shares I’m really liking at the moment.
More European growth for PolyNovo (ASX:PNV) shares
Polynovo Ltd (ASX:PNV) shares are on watch today after the company announced expansion in Europe.
Is the PolyNovo (ASX: PNV) share price a buy today?
Shares in S&P/ASX 200 (ASX: XJO) company PoloNovo Ltd (ASX: PNV) have rallied in recent months following a string of positive announcements.
Why the PolyNovo (ASX:PNV) share price soared 9% yesterday
The PolyNovo Ltd (ASX: PNV) share price shot up 8.73% yesterday after announcing Taiwan FDA approval. Is it time to buy PolyNovo shares?